InCube Ventures II L.P. 13D and 13G filings for Rani Therapeutics Holdings, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2022-02-14 07:33 am Purchase | 2021-12-31 | 13G | Rani Therapeutics Holdings, Inc. RANI | InCube Ventures II L.P. | 2,566,113 11.500% | 2,566,113 (New Position) | Filing |